Skip to content

Hypnotic effect of Lactuca sativa seed in patients with insomnia

Hypnotic effect of Lactuca sativa seed in patients with insomnia: a randomized double-blind clinical trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200128046288N1
Enrollment
60
Registered
2020-04-15
Start date
2020-03-18
Completion date
Unknown
Last updated
2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary insomnia. Primary insomnia

Interventions

Intervention 1: Intervention group: They will receive 15 ml of lettuce seed syrup that will be made by the researchers of the present Project, every night for four weeks. Each 15 ml of syrup contains

Sponsors

Ahvaz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: People 20 to 50 years History of Primary Insomnia Disorder (People with sleep disorders have difficulty starting and maintaining sleep and feel tired and restless after waking up. Their daily functioning decrease and they are constantly thinking of having a restful sleep. The women in the study had a negative pregnancy test and had appropriate prevention methods during the study. No history of asthma and heart disease (heart block and heart failure) Patients should not use analgesic drugs regularly for any reason

Exclusion criteria

Exclusion criteria: A history of secondary insomnia disorder, such as insomnia from medication use, or sleep disorder related to another mental disorder Pregnancy and Lactation History of heart, kidney or liver disease History of neurological and neurological diseases History of diabetes

Design outcomes

Primary

MeasureTime frame
Subjective sleep quality. Timepoint: In addition to the first visit, patients will be visit at the end of the fourth week after receiving the medication. Method of measurement: Pittsburgh Sleep Quality Questionnaire.;Sleep Time. Timepoint: In addition to the first visit, patients will be visit at the end of the fourth week after receiving the medication. Method of measurement: Pittsburgh Sleep Quality Questionnaire.;Sleep Duration. Timepoint: In addition to the first visit, patients will be visit at the end of the fourth week after receiving the medication. Method of measurement: Pittsburgh Sleep Quality Questionnaire.;Daytime dysfunction. Timepoint: In addition to the first visit, patients will be visit at the end of the fourth week after receiving the medication. Method of measurement: Pittsburgh Sleep Quality Questionnaire.

Secondary

MeasureTime frame
The rate of drug side effects. Timepoint: During drug use. Method of measurement: Patient Report.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFereshteh Golfakhrabadi

Ahvaz University of Medical Sciences

golfakhrabadi@yahoo.com+98 61 3373 8378

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026